UK markets open in 2 hours 15 minutes

Sumitomo Pharma Co., Ltd. (DNPUF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.5950+0.1950 (+8.12%)
At close: 03:38PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
330,307,000
555,544,000
560,035,000
515,952,000
Cost of revenue
132,343,000
178,919,000
157,127,000
137,773,000
Gross profit
197,964,000
376,625,000
402,908,000
378,179,000
Operating expenses
Research development
129,509,000
131,858,000
94,903,000
132,682,000
Selling general and administrative
275,405,000
373,316,000
249,081,000
190,373,000
Total operating expenses
374,911,000
453,604,000
342,674,000
306,955,000
Operating income or loss
-176,947,000
-76,979,000
60,234,000
71,224,000
Interest expense
3,214,000
3,159,000
3,050,000
2,586,000
Income before tax
-155,303,000
-47,920,000
82,961,000
77,851,000
Income tax expense
26,483,000
48,794,000
42,361,000
41,022,000
Income from continuing operations
-181,786,000
-96,714,000
40,600,000
36,829,000
Net income
-173,718,000
-74,512,000
56,413,000
56,219,000
Net income available to common shareholders
-173,718,000
-74,512,000
56,413,000
56,219,000
Basic EPS
-339.73
-187.55
141.99
141.50
Diluted EPS
-339.73
-187.55
141.99
141.50
Basic average shares
397,292
397,292
397,293
397,294
Diluted average shares
397,292
397,292
397,293
397,294